Market revenue in 2023 | USD 6,359.8 million |
Market revenue in 2030 | USD 14,815.9 million |
Growth rate | 12.8% (CAGR from 2023 to 2030) |
Largest segment | Spinal cord stimulator |
Fastest growing segment | Gastric Electric Stimulator |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Electric Stimulator |
Spinal cord stimulator was the largest segment with a revenue share of 51.08% in 2023. Horizon Databook has segmented the Global neurostimulation devices market based on spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, gastric electric stimulator covering the revenue growth of each sub-segment from 2018 to 2030.
The neurostimulation devices market has a high growth potential. Manufacturers continue to undertake extensive R&D activities to develop new products and advanced technologies. In addition, technological advancements in neurostimulation devices are expected to drive market growth during the forecast period.
For instance, in June 2021, Aleva Neurotherapeutics, a developer of implants for deep brain stimulation (DBS) in major neurological indications such as Parkinson's disease and essential tremor, today announced the successful implantation of a first patient with the directSTIMTM Directional Deep Brain Stimulation System.
Aleva is aiming to obtain IDE approval by the US FDA in Q4, 2021. Moreover, technologies such as gastric, hypoglossal, and carotid artery stimulation systems are under development, which are expected to contribute to market growth during the forecast period.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account